Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome [Phase 1]
Phase 1 trial investigating gemcitabine and pemetrexed disodium in advanced mycosis fungoides or Sézary syndrome (a form of cutaneous T-cell…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia [Phase 2]
Phase 2 trial evaluating combination chemotherapy with rituximab for newly diagnosed Burkitt's lymphoma or leukemia has completed; results p…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer [Phase 2]
Phase 2 trial update on a combination chemotherapy, bone marrow transplant, and post-transplant cyclophosphamide regimen for hematologic can…
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Improving Communication in Older Cancer Patients and Their Caregivers [NA]
A completed clinical trial focused on improving communication in older cancer patients and their caregivers, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy [Phase 3]
A Phase 3 clinical trial comparing proton pump inhibitors versus histamine antagonists as an adjuvant to chemotherapy for lymphoma is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides [Phase 3]
A Phase 3 trial evaluating doxycycline for early-stage mycosis fungoides in lymphoma patients is underway, with efficacy results not yet spe…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Lenalidomide and R-CHOP in B-cell Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the combination of lenalidomide with R-CHOP in various B-cell lymphomas; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy [Phase 3]
Phase 3 trial ofInotuzumab Ozogamicin plus Rituximab for relapsed/refractory aggressive non-Hodgkin lymphoma in patients unsuitable for high…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]
Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and l…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or stem cell transplantation in refractory Hodgkin's dise…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating busulfan plus clofarabine followed by allogeneic hematopoietic stem cell transplantation for leukemia and lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma [Phase 2]
Phase 2 clinical trial update on using chidamide maintenance after autologous stem cell transplantation in relapsed/refractory or high-risk …
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab [Phase 2]
Phase 2 trial update on optimized donor selection with nonmyeloablative bone marrow transplant using post-transplant cyclophosphamide and ri…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Evaluation of ClearLLab Leukemia and Lymphoma Panels
Completed clinical trial evaluating Beckman Coulter's ClearLLab leukemia and lymphoma panels for diagnostic use in leukemia and lymphoma con…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating vorinostat and rituximab in indolent non-Hodgkin lymphoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
A completed clinical trial evaluating fluorodeoxyglucose-positron emission tomography (FDG-PET) for evaluating autoimmune lymphoproliferativ…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers [Phase 2]
Phase 2 trial evaluating reduced-intensity, related-donor bone marrow transplantation followed by high-dose cyclophosphamide for hematologic…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
The document reports the completion and update of a clinical trial evaluating loratadine for G-CSF–induced bone pain in patients with leukem…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain [Phase 2]
Phase 2 trial of pregabalin for G-CSF-induced bone pain in patients with breast cancer or lymphoma was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers [Phase 1, Phase 2]
Phase 1/2 open-label dose-escalation study of IONIS-STAT3Rx in patients with advanced cancers, including diffuse large B-cell lymphoma, has …
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Allogeneic Transplant in HIV Patients (BMT CTN 0903) [Phase 2]
Phase 2 clinical trial evaluating allogeneic transplant in HIV-positive patients with leukemia or lymphoma; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation
A clinical trial investigates whether higher infused autologous lymphocyte counts lead to a stronger antibody response to immunization after…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Phase I Trial of PX-478 [Phase 1]
This Phase I trial of PX-478 has completed. The study involved patients with lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: EBUS-TBNA vs Flex 19G EBUS-TBNA [NA]
This clinical trial update reports the completion of a study comparing EBUS-TBNA with Flex 19G EBUS-TBNA.
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients [EARLY_Phase 1]
Early Phase 1 trial results validate an insulin protocol for managing glucocorticoid-induced hyperglycemia in patients with lymphoma and typ…